Subantimicrobial dose doxycycline treatment increases serum cholesterol efflux capacity from macrophages

OBJECTIVE: Subantimicrobial dose doxycycline (SDD) treatment has been reported to reduce the severity of chronic inflammation and to increase serum HDL cholesterol. We determined in a double-blind, placebo-controlled clinical trial, whether SDD affects the ability of serum to facilitate cholesterol...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Salminen, Aino, Pussinen, Pirkko J., Payne, Jeffrey B., Stoner, Julie A., Jauhiainen, Matti, Golub, Lorne M., Lee, Hsi-Ming, Thompson, David M., Sorsa, Timo
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3700361/
https://ncbi.nlm.nih.gov/pubmed/23649042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00011-013-0626-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares